PET imaging with 11C-acetate in prostate cancer: A biochemical, radiochemical and clinical perspective

36Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose: In the present study, the potential clinical role of 11C-acetate PET mainly in the differential diagnosis, in the staging and in the follow-up of prostate cancer patients is reported. Methods: Each of the above points has been accurately investigated by studying the specific biochemical and radiobiochemical behaviour of this positron emitter compound. Results and Conclusion: The imaging quality of 11C-acetate PET and its unique mechanisms of cellular uptake, make such radiotracer a powerful tool in evaluating all the steps of the prostatic cancer. © 2007 Springer-Verlag.

Cite

CITATION STYLE

APA

Soloviev, D., Fini, A., Chierichetti, F., Al-Nahhas, A., & Rubello, D. (2008, May). PET imaging with 11C-acetate in prostate cancer: A biochemical, radiochemical and clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-007-0662-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free